cytotoxic T-lymphocyte antigen-4

cytotoxic T-lymphocyte antigen-4 (CTLA-4),

expressed by activated T cells. When synthesized as a soluble molecule fused to the Fc of IgG, it is used as a biologic therapy in rhematic diseases, because it blocks a costimulatory molecule on B lymphocytes.